Thiazole compound and use thereof
An object of the present invention is to provide a novel thiazole compound with specific inhibitory activity against phosphodiesterase 4. The present invention provides a compound represented by Formula (1), an optical isomer thereof, or a salt thereof: wherein R1 is a di-C 1-6 alkoxyphenyl group; R...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | TAKEMURA ISAO,WATANABE KENJI,OSHIMA KUNIO,ITO NOBUAKI,HARUTA JUNPEI,HIYAMA HIDETAKA,CHIHIRO MASATOSHI,KAWASOME HIDEKI,SAKAMOTO YOKO,ISHIYAMA HIRONOBU,SUMIDA TAKUMI,FUJITA KAZUHIKO,KITAGAKI HIDEKI |
description | An object of the present invention is to provide a novel thiazole compound with specific inhibitory activity against phosphodiesterase 4. The present invention provides a compound represented by Formula (1), an optical isomer thereof, or a salt thereof:
wherein R1 is a di-C 1-6 alkoxyphenyl group; R2 is any one of the following groups (a) to (t): (a) a phenyl group; (b) a naphthyl group; (c) a pyridyl group; (d) a furyl group; (e) a thienyl group; (f) an isoxazolyl group; (g) a thiazolyl group; (h) a pyrrolyl group; (i) an imidazolyl group; (j) a tetrazolyl group; (k) a pyrazinyl group; (1) a thienothienyl group; (m) a benzothienyl group; (n) an indolyl group; (o) a benzimidazolyl group; (p) an indazolyl group; (q) a quinolyl group; (r) a 1,2,3,4-tetrahydroquinolyl group; (s) a quinoxalinyl group; and (t) a 1,3-benzodioxolyl group; and A is any one of the following groups (i) to (vi): (i) -CO-B- wherein B is a C 1-6 alkylene group; (ii) -CO-Ba wherein Ba is a C 2-6 alkenylene group; (iii) -CH(OH)-B-; (iv) -COCH(COOR3)-Bb- wherein R3 is a C 1-6 alkyl group and Bb is a C 1-6 alkylene group; and (v) -Bc- wherein Bc is a C 2-6 alkylene group. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN1953968A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN1953968A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN1953968A3</originalsourceid><addsrcrecordid>eNrjZFAMychMrMrPSVVIzs8tyC_NS1FIBOLS4lSFkozUotT8NB4G1rTEnOJUXijNzSDv5hri7KGbWpAfn1pckJicmpdaEu_sZ2hpamxpZuFoTFgFAPOoJOg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Thiazole compound and use thereof</title><source>esp@cenet</source><creator>TAKEMURA ISAO,WATANABE KENJI,OSHIMA KUNIO,ITO NOBUAKI,HARUTA JUNPEI,HIYAMA HIDETAKA,CHIHIRO MASATOSHI,KAWASOME HIDEKI,SAKAMOTO YOKO,ISHIYAMA HIRONOBU,SUMIDA TAKUMI,FUJITA KAZUHIKO,KITAGAKI HIDEKI</creator><creatorcontrib>TAKEMURA ISAO,WATANABE KENJI,OSHIMA KUNIO,ITO NOBUAKI,HARUTA JUNPEI,HIYAMA HIDETAKA,CHIHIRO MASATOSHI,KAWASOME HIDEKI,SAKAMOTO YOKO,ISHIYAMA HIRONOBU,SUMIDA TAKUMI,FUJITA KAZUHIKO,KITAGAKI HIDEKI</creatorcontrib><description>An object of the present invention is to provide a novel thiazole compound with specific inhibitory activity against phosphodiesterase 4. The present invention provides a compound represented by Formula (1), an optical isomer thereof, or a salt thereof:
wherein R1 is a di-C 1-6 alkoxyphenyl group; R2 is any one of the following groups (a) to (t): (a) a phenyl group; (b) a naphthyl group; (c) a pyridyl group; (d) a furyl group; (e) a thienyl group; (f) an isoxazolyl group; (g) a thiazolyl group; (h) a pyrrolyl group; (i) an imidazolyl group; (j) a tetrazolyl group; (k) a pyrazinyl group; (1) a thienothienyl group; (m) a benzothienyl group; (n) an indolyl group; (o) a benzimidazolyl group; (p) an indazolyl group; (q) a quinolyl group; (r) a 1,2,3,4-tetrahydroquinolyl group; (s) a quinoxalinyl group; and (t) a 1,3-benzodioxolyl group; and A is any one of the following groups (i) to (vi): (i) -CO-B- wherein B is a C 1-6 alkylene group; (ii) -CO-Ba wherein Ba is a C 2-6 alkenylene group; (iii) -CH(OH)-B-; (iv) -COCH(COOR3)-Bb- wherein R3 is a C 1-6 alkyl group and Bb is a C 1-6 alkylene group; and (v) -Bc- wherein Bc is a C 2-6 alkylene group.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070425&DB=EPODOC&CC=CN&NR=1953968A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070425&DB=EPODOC&CC=CN&NR=1953968A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAKEMURA ISAO,WATANABE KENJI,OSHIMA KUNIO,ITO NOBUAKI,HARUTA JUNPEI,HIYAMA HIDETAKA,CHIHIRO MASATOSHI,KAWASOME HIDEKI,SAKAMOTO YOKO,ISHIYAMA HIRONOBU,SUMIDA TAKUMI,FUJITA KAZUHIKO,KITAGAKI HIDEKI</creatorcontrib><title>Thiazole compound and use thereof</title><description>An object of the present invention is to provide a novel thiazole compound with specific inhibitory activity against phosphodiesterase 4. The present invention provides a compound represented by Formula (1), an optical isomer thereof, or a salt thereof:
wherein R1 is a di-C 1-6 alkoxyphenyl group; R2 is any one of the following groups (a) to (t): (a) a phenyl group; (b) a naphthyl group; (c) a pyridyl group; (d) a furyl group; (e) a thienyl group; (f) an isoxazolyl group; (g) a thiazolyl group; (h) a pyrrolyl group; (i) an imidazolyl group; (j) a tetrazolyl group; (k) a pyrazinyl group; (1) a thienothienyl group; (m) a benzothienyl group; (n) an indolyl group; (o) a benzimidazolyl group; (p) an indazolyl group; (q) a quinolyl group; (r) a 1,2,3,4-tetrahydroquinolyl group; (s) a quinoxalinyl group; and (t) a 1,3-benzodioxolyl group; and A is any one of the following groups (i) to (vi): (i) -CO-B- wherein B is a C 1-6 alkylene group; (ii) -CO-Ba wherein Ba is a C 2-6 alkenylene group; (iii) -CH(OH)-B-; (iv) -COCH(COOR3)-Bb- wherein R3 is a C 1-6 alkyl group and Bb is a C 1-6 alkylene group; and (v) -Bc- wherein Bc is a C 2-6 alkylene group.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAMychMrMrPSVVIzs8tyC_NS1FIBOLS4lSFkozUotT8NB4G1rTEnOJUXijNzSDv5hri7KGbWpAfn1pckJicmpdaEu_sZ2hpamxpZuFoTFgFAPOoJOg</recordid><startdate>20070425</startdate><enddate>20070425</enddate><creator>TAKEMURA ISAO,WATANABE KENJI,OSHIMA KUNIO,ITO NOBUAKI,HARUTA JUNPEI,HIYAMA HIDETAKA,CHIHIRO MASATOSHI,KAWASOME HIDEKI,SAKAMOTO YOKO,ISHIYAMA HIRONOBU,SUMIDA TAKUMI,FUJITA KAZUHIKO,KITAGAKI HIDEKI</creator><scope>EVB</scope></search><sort><creationdate>20070425</creationdate><title>Thiazole compound and use thereof</title><author>TAKEMURA ISAO,WATANABE KENJI,OSHIMA KUNIO,ITO NOBUAKI,HARUTA JUNPEI,HIYAMA HIDETAKA,CHIHIRO MASATOSHI,KAWASOME HIDEKI,SAKAMOTO YOKO,ISHIYAMA HIRONOBU,SUMIDA TAKUMI,FUJITA KAZUHIKO,KITAGAKI HIDEKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN1953968A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TAKEMURA ISAO,WATANABE KENJI,OSHIMA KUNIO,ITO NOBUAKI,HARUTA JUNPEI,HIYAMA HIDETAKA,CHIHIRO MASATOSHI,KAWASOME HIDEKI,SAKAMOTO YOKO,ISHIYAMA HIRONOBU,SUMIDA TAKUMI,FUJITA KAZUHIKO,KITAGAKI HIDEKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAKEMURA ISAO,WATANABE KENJI,OSHIMA KUNIO,ITO NOBUAKI,HARUTA JUNPEI,HIYAMA HIDETAKA,CHIHIRO MASATOSHI,KAWASOME HIDEKI,SAKAMOTO YOKO,ISHIYAMA HIRONOBU,SUMIDA TAKUMI,FUJITA KAZUHIKO,KITAGAKI HIDEKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Thiazole compound and use thereof</title><date>2007-04-25</date><risdate>2007</risdate><abstract>An object of the present invention is to provide a novel thiazole compound with specific inhibitory activity against phosphodiesterase 4. The present invention provides a compound represented by Formula (1), an optical isomer thereof, or a salt thereof:
wherein R1 is a di-C 1-6 alkoxyphenyl group; R2 is any one of the following groups (a) to (t): (a) a phenyl group; (b) a naphthyl group; (c) a pyridyl group; (d) a furyl group; (e) a thienyl group; (f) an isoxazolyl group; (g) a thiazolyl group; (h) a pyrrolyl group; (i) an imidazolyl group; (j) a tetrazolyl group; (k) a pyrazinyl group; (1) a thienothienyl group; (m) a benzothienyl group; (n) an indolyl group; (o) a benzimidazolyl group; (p) an indazolyl group; (q) a quinolyl group; (r) a 1,2,3,4-tetrahydroquinolyl group; (s) a quinoxalinyl group; and (t) a 1,3-benzodioxolyl group; and A is any one of the following groups (i) to (vi): (i) -CO-B- wherein B is a C 1-6 alkylene group; (ii) -CO-Ba wherein Ba is a C 2-6 alkenylene group; (iii) -CH(OH)-B-; (iv) -COCH(COOR3)-Bb- wherein R3 is a C 1-6 alkyl group and Bb is a C 1-6 alkylene group; and (v) -Bc- wherein Bc is a C 2-6 alkylene group.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_CN1953968A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Thiazole compound and use thereof |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T08%3A34%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAKEMURA%20ISAO,WATANABE%20KENJI,OSHIMA%20KUNIO,ITO%20NOBUAKI,HARUTA%20JUNPEI,HIYAMA%20HIDETAKA,CHIHIRO%20MASATOSHI,KAWASOME%20HIDEKI,SAKAMOTO%20YOKO,ISHIYAMA%20HIRONOBU,SUMIDA%20TAKUMI,FUJITA%20KAZUHIKO,KITAGAKI%20HIDEKI&rft.date=2007-04-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN1953968A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |